Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This is a phase 2 study that will consist of 4 visits over a 5 week period. Drug will be evaluated using the conjunctival allergen challenge model of allergic conjunctivitis.
Epistemonikos ID: b18909134f6b7e4d686178365bf7e82fc1b78caa
First added on: May 05, 2024